| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/05/2008 | US7407982 Polyoxyethylene glycol conjugates mean the drug is eliminated almost completely through the kidneys; bioavailability; anticoagulants |
| 08/05/2008 | US7407947 liposomes containing a sterol skeleton based compound wherein one or several amphoteric groups with an isoelectric point of between 4 and 9 are substituted on the 3rd position of the ring system |
| 08/05/2008 | US7407944 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends |
| 08/05/2008 | US7407939 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics |
| 08/05/2008 | US7407932 Exendin agonist composed of a peptide in which at least one amino acid residue is acylated with a dicarboxylic acid; the amino acid residues are an internal lysine residue, an N-terminal amino acid residue, and/or a C-terminal amino acid residue; treatment of glucagonoma |
| 08/05/2008 | US7407912 Supersuperabsorbent polymers |
| 08/05/2008 | US7407779 Modification of solid 3-sn-phosphoglycerides |
| 08/05/2008 | US7407676 Recovering lignans from plants; obtain plant biomass, expose to extraction solvent, separate solid plant material, remove microorganism from extraction solution, recover lignan |
| 08/05/2008 | US7407671 A crosslinked thermosensitive cellulose gel on a medical device and loaded with a solute is positioned within the body and heated to body temperature to release the solute upon gel shrinkage |
| 08/05/2008 | US7407670 Drug having a solubility of less than 1 gram per liter in an aqueous environment dispersed in a vinyl acetate-vinylpyrrolidone copolymer and a second polymer that enhances the dissolution of the drug and is a cationic polymer of 2-(dimethylamino)ethyl methacrylate and a neutral methacrylic ester |
| 08/05/2008 | US7407669 film delivers at least one oral care agent, such as antimicrobial agents and salivary stimulants |
| 08/05/2008 | US7407656 PSCA: prostate stem cell antigen and uses thereof |
| 08/05/2008 | US7407655 Method of inhibiting leukocytes with human CXC chemokine receptor 3 antibody |
| 08/05/2008 | US7407651 IFN-β liquid formulations |
| 08/05/2008 | US7407475 Modified annexin proteins, and methods and compositions for using them |
| 08/05/2008 | CA2398035C Timed pulsatile drug delivery systems |
| 08/05/2008 | CA2380902C Process to make a sustained release formulation |
| 08/05/2008 | CA2374930C Microreservoir system based on polysiloxanes and ambiphilic solvents |
| 08/05/2008 | CA2328436C Comb copolymers for regulating cell-surface interactions |
| 08/05/2008 | CA2326502C Effervescent formulations |
| 08/05/2008 | CA2324265C Liquid polymeric compositions for controlled release of bioactive substances |
| 08/05/2008 | CA2323627C Latent reactive blood compatible agents |
| 08/05/2008 | CA2319015C Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations |
| 08/05/2008 | CA2217494C Novel compositions of lipids and stabilizing materials |
| 08/05/2008 | CA2186750C Use of fatty acid esters as bioadhesive substances |
| 08/05/2008 | CA2180205C Triazinyl or pyrimidinyl group-containing amino-silicones |
| 08/05/2008 | CA2113243C Pharmaceutical compositions containing nanocapsules |
| 08/05/2008 | CA2111199C Pharmaceutical formulations of osteogenic proteins |
| 07/31/2008 | WO2008092084A2 Injectable non-aqueous suspension with high concentration of therapeutic agent |
| 07/31/2008 | WO2008091747A1 Polymers of aliphatic thioester |
| 07/31/2008 | WO2008091591A1 Polypeptide films and methods |
| 07/31/2008 | WO2008091530A2 Diagnostic and therapeutic cyclooxygenase-2 binding ligands |
| 07/31/2008 | WO2008091170A1 A preparation containing sodium butyrate and the application of a preparation containing sodium butyrate |
| 07/31/2008 | WO2008090732A1 Pharmaceutical composition |
| 07/31/2008 | WO2008090585A2 Soluble forms of inclusion complexes of histone deacetylase inhibitors and cyclodextrins, their preparation processes and uses in the pharmaceutical field |
| 07/31/2008 | WO2008090569A1 Modified release pharmaceutical composition and a process of making the same |
| 07/31/2008 | WO2008090440A1 Lipid-based gynaecologic suppository |
| 07/31/2008 | WO2008090076A1 Oral pharmaceutical compositions in the form of stabilised aqueous solutions |
| 07/31/2008 | WO2008090038A1 Pulverulent pharmaceutical composition comprising ibuprofen and a polyalcohol |
| 07/31/2008 | WO2008089773A1 Formulation of a rapidly disintegrating matrix |
| 07/31/2008 | WO2008089771A1 Dna controlled assembly of lipid membranes |
| 07/31/2008 | WO2008089709A2 Oxaliplatin pharmaceutical composition with alcoholic sugar-based buffer |
| 07/31/2008 | WO2008089706A1 A two-component taxane containing pharmaceutical composition |
| 07/31/2008 | WO2008089593A1 Sustained release tamsulosin formulation and producing method |
| 07/31/2008 | WO2008089567A1 Cancerous disease modifying antibodies |
| 07/31/2008 | WO2008089566A1 Cancerous disease modifying antibodies |
| 07/31/2008 | WO2008089565A1 Cancerous disease modifying antibodies |
| 07/31/2008 | WO2008089549A1 Pharmaceutical compositions comprising nebivolol or a nebivolol analogue |
| 07/31/2008 | WO2008075984A3 Tablet formulation including macrocyclic lactone and levamisole anthelmintic agents |
| 07/31/2008 | WO2008071594A3 Polypeptides with the capacity to entrap drugs |
| 07/31/2008 | WO2008062440A3 Programmable buoyant delivery technology |
| 07/31/2008 | WO2008062435A3 Stabilised dosage forms of amlodipine besylate |
| 07/31/2008 | WO2008061226A3 Sustained-release formulations of topiramate |
| 07/31/2008 | WO2008030359A3 Topical compositions |
| 07/31/2008 | WO2008027263A3 Stimuli responsive polyester amide particles |
| 07/31/2008 | WO2008011836A3 Ophthalmic solutions |
| 07/31/2008 | WO2008011087A3 Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease |
| 07/31/2008 | WO2007109244A3 Novel nanoparticles for delivery of active agents |
| 07/31/2008 | WO2007103132A3 Method and apparatus for acne treatment using low intensity light therapy |
| 07/31/2008 | WO2007075720A8 Topical mecamylamine formulations for ocular administration and uses thereof |
| 07/31/2008 | WO2007065036A3 Therapeutic conjugates and methods of using same |
| 07/31/2008 | WO2007008563A3 Preparation of pegylated conjugates of vla-4 antagonists via a mitsunobu' s reaction |
| 07/31/2008 | US20080182981 Method and medicament for inhibiting the expression of a given gene |
| 07/31/2008 | US20080182959 Novel Temperature and pH Sensitive Copolymers |
| 07/31/2008 | US20080182915 Aqueous olefin polymer dispersion made using a complex catalyst prepared by reacting a benzoquinone or dimer (2,3,5,6-tetrachloro-para-benzoquinone), a phosphine or diphosphine (potassium salt of 4-(diphenylphosphino)benzenesulfonic acid), and a transition metal compound [nickel (1,5-cyclooctadiene)2] |
| 07/31/2008 | US20080182909 Methods for stabilizing biologically active agents encapsulated in biodegradable controlled-release polymers |
| 07/31/2008 | US20080182792 Diminishing presence of protein aggregates in an environment susceptible to formation of protein aggregate by introducing into environment a compound having two domains, a first domain that binds to protein aggregation having two monomers, and a second domain binding to diminishing protein |
| 07/31/2008 | US20080182776 Drug-loaded poly (alkyl-cyanoacrylate) nanoparticles and process foe the preparation thereof |
| 07/31/2008 | US20080181966 Modafinil pharmaceutical compositions |
| 07/31/2008 | US20080181964 Microparticles |
| 07/31/2008 | US20080181960 Solid dispersion of completely amorphous carotenoids; polyvinylpyrrolidone, hydroxypropylcellulose hydroxypropylmethylcellulose solubility-enhancing polymers;spray dried powder increased bulk density; substantially free of lipids and oils |
| 07/31/2008 | US20080181951 Treatment of humans with colloidal silver composition |
| 07/31/2008 | US20080181946 Controlled Release Delivery System For Metformin |
| 07/31/2008 | US20080181944 semipermeable walled container that houses a capsule comprising a drug formulation, a piston, and an osmotic composition; releases the drug through a passageway at controlled rate over a sustained release period of time; progestin and estrogen |
| 07/31/2008 | US20080181939 hydrolysis triggered, controlled release polymersome nano-system for delivering a cytotoxic, anticancer therapeutic active agent to cell; stable, synthetic, self-assembling, controlled release, polyethylene oxide-based vesicles; semi-permeable, thin-walled, amphiphilic, high molecular weight |
| 07/31/2008 | US20080181934 medication are delivered in pleasant tasting delivery vehicles, including gelatins and candies; kits; to mask noxious taste |
| 07/31/2008 | US20080181931 Antimicrobial medical devices including silver nanoparticles |
| 07/31/2008 | US20080181917 Methods for therapeutic treatment of carpal tunnel syndrome |
| 07/31/2008 | US20080181914 an inactivated, disrupted influenza virus preparation of a hemagglutinin antigen stabilised by alpha-tocopherol succinate in the absence or at low levels of thiomersal; hemagglutinin detectable by a single radial immunoassay (SRID); mercury-free preservative; administering by any route |
| 07/31/2008 | US20080181909 Chimeric immunomodulatory compounds and methods of using the same |
| 07/31/2008 | US20080181885 202P5A5 gene or fragment or its encoded protein, or variants , or a fragment, used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 202P5A5 be used in active or passive immunization; gene therapy, immunotherapy; anticarcinogenic agent biodrug for pancreatic cancer |
| 07/31/2008 | US20080181884 administering a synergistic mixture comprising an antibody, Anidulafungin (LY303366) and amphotericin B; for drug resistanct infections; induce immunology response; diagnosis of a patient with a Coccidioidomycosis infection |
| 07/31/2008 | US20080181854 antiinflammatory ascomycin derivative pimecrolimus in the form of a foam; inflammatory and hyperproliferative skin diseases and of cutaneous manifestations of immunologically-mediated diseases |
| 07/31/2008 | US20080181852 water soluble polyglutamnylglutamine conjugated to drugs, polydentate ligands, targeting, optical imaging, magnetic resonance imaging or stabilizing agents, having improved bioavailability |
| 07/31/2008 | US20080181849 Methods, kits and compositions comprising crotamine |
| 07/31/2008 | DE4400295B4 Verfahren zum Herstellen eines sphärischen Granulums A method for producing a spherical granule |
| 07/31/2008 | DE202008007318U1 Langzeitstabile pharmazeutische Zubereitung mit dem Wirkstoff Glyceroltrinitrat Long-term stable pharmaceutical composition containing the active ingredient nitroglycerin |
| 07/31/2008 | CA2676008A1 Compositions and methods for diagnosing and treating cancer |
| 07/31/2008 | CA2675972A1 Polypeptide films and methods |
| 07/31/2008 | CA2675788A1 Oxaliplatin pharmaceutical composition with alcoholic sugar-based buffer |
| 07/31/2008 | CA2675538A1 Pharmaceutical compositions comprising nebivolol or a nebivolol analogue |
| 07/31/2008 | CA2675293A1 Cancerous disease modifying antibodies |
| 07/31/2008 | CA2675292A1 Cancerous disease modifying antibodies |
| 07/31/2008 | CA2674897A1 Cancerous disease modifying antibodies |
| 07/31/2008 | CA2619193A1 Polyphenol-based composition, and methods and systems for its preparation |
| 07/30/2008 | EP1950294A1 Novel cell penetrating peptide |
| 07/30/2008 | EP1950227A1 HYDROXYPROPYL-SULFOBUTYL-ß-CYCLODEXTRIN, THE PREPARATION METHOD,THE ANALYTICAL METHOD AND THE PHARMACUTICAL APPLICATION THEREOF |
| 07/30/2008 | EP1950224A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1950223A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1950205A1 Method for stabilization of isoxazole compound |